Nasdaq - Delayed Quote
USD
Eventide Gilead A (ETAGX)
57.39
-0.76
(-1.31%)
At close: November 2 at 6:06:07 PM EST
Performance Overview
| Morningstar Return Rating | -- |
| YTD Return | 10.81% |
|---|---|
| 5y Average Return | 1.26% |
| Number of Years Up | 12 |
| Number of Years Down | 4 |
| Best 1Y Total Return (Oct 29, 2026) | 55.06% |
| Worst 1Y Total Return (Oct 29, 2026) | -- |
| Best 3Y Total Return | 55.06% |
| Worst 3Y Total Return | -6.97% |
Trailing Returns (%) Vs. Benchmarks
Monthly Total Returns
ETAGX
Category
- YTD
- 13.32%
- 10.80%
- 1-Month
- -0.84%
- 4.43%
- 3-Month
- -7.61%
- 7.00%
- 1-Year
- 18.93%
- 48.17%
- 3-Year
- 15.87%
- 21.26%
- 5-Year
- 2.93%
- 20.18%
- 10-Year
- 12.80%
- 14.07%
- Last Bull Market
- 29.94%
- 27.14%
- Last Bear Market
- -20.11%
- -21.26%
Annual Total Return (%) History
Year
ETAGX
Category
Past Quarterly Returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
|
2026
|
-6.91% | 31.76% | -7.61% | -- |
|
2025
|
-8.05% | 17.98% | 8.43% | 4.95% |
|
2024
|
2.89% | -7.42% | 4.50% | 0.20% |
|
2023
|
8.64% | 8.09% | -6.46% | 11.49% |
|
2022
|
-16.28% | -20.11% | -0.39% | -1.06% |
|
2021
|
-0.30% | 11.02% | -1.88% | 2.59% |
|
2020
|
-18.85% | 41.58% | 12.40% | 20.08% |
|
2019
|
27.84% | 3.10% | -8.08% | 10.40% |
|
2018
|
2.20% | 7.97% | 6.27% | -16.92% |
|
2017
|
8.68% | 7.02% | 6.46% | 7.26% |
Rank in Category (By Total Return)
| YTD | 13 |
| 1-Month | 20 |
|---|---|
| 3-Month | 68 |
| 1-Year | 4 |
| 3-Year | 38 |
| 5-Year | 49 |
Load Adjusted Returns
| 1-Year | 12.09% |
| 3-Year | 13.60% |
|---|---|
| 5-Year | 1.72% |
| 10-Year | 12.14% |
Performance & Risk
| YTD Return | 10.81% |
| 5y Average Return | 1.26% |
| Rank in Category (ytd) | 13 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 1.36 |
| Morningstar Risk Rating |
Fund Overview
| Category | Mid-Cap Growth |
| Fund Family | Eventide Funds |
| Net Assets | 3.16B |
| YTD Return | 13.32% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | Feb 02, 2010 |
Fund Summary
Normally, the fund invests primarily in a broad range of equity securities of any market capitalization. It may invest without limitation in securities in companies domiciled outside the United States either directly or through ADRs. From time to time, the fund may invest a substantial portion of its assets in the stock of companies in one or more sectors of the economy, such as the technology, industrial, healthcare and life sciences sectors.
